Age-adjusted annual percent changes (APC) in incidence (A), mortality (B), and prevalence (C) rates per 100,000 over 2014–2023 for both sexes and sex-specific. by Ayana Ablayeva (22103708)

Negative Intrinsic Viscosity in Graphene Nanoparticle Suspensions Induced by Hydrodynamic Slip by Adyant Agrawal (22492518)

“…As the concentration of graphene particles increases in the dilute regime, the viscosity initially decreases, falling below that of pure water. At higher concentrations, however, particle aggregation becomes significant, leading to a rise in viscosity after a minimum is reached. …”

Negative Intrinsic Viscosity in Graphene Nanoparticle Suspensions Induced by Hydrodynamic Slip by Adyant Agrawal (22492518)

“…As the concentration of graphene particles increases in the dilute regime, the viscosity initially decreases, falling below that of pure water. At higher concentrations, however, particle aggregation becomes significant, leading to a rise in viscosity after a minimum is reached. …”

Status (A) and duration (B) of breast feeding among participants. by Sara Saleh (6733619)

The experimental technology combining a fluid shear stress experimental system with Atomic Force Microscopy (AFM). by Xinyao Zhao (5824427)

The diagram shows the mean IC-volume of both sides as a function of age with the degree of hearing loss as defined in the methods from class 1 (normal to moderate in both ears) to... by Pingling Kwok (14896191)

Graphical representation of surface roughness values on the specimen surface after tests conducted at different time intervals (a) Ra, Rq (b) Rz (c) Sa, Sq (d) Sz, Sp, Sv. by Yang Li (7082)

Co-Contraction index of right and left gluteus medius activity (MVC%) during 60 minutes standing (time- condition) between two groups (A: used the footrest intermittently, B: used... by Saeedeh Abbasi (9423189)

Redundancy Analysis (RDA) between the mineral element contents and the relative abundance of the major phyla/class of endophytic bacterial communities in the leaves (A) and roots (... by Rabiath F. R. Adigoun (14189090)

Non-metric multidimensional scaling (NMDS) plots of endophytic bacterial communities at OTUs level calculated with the method of Bray Curtis according to the plant tissue (A), phen... by Rabiath F. R. Adigoun (14189090)

AUC of various models to predict imeglimin efficacy for liver function evaluated by ROC curves. by Naruyoshi Gyoutoku (22537831)

Subjects:

Logistic regression analysis to predict the efficacy for liver function. by Naruyoshi Gyoutoku (22537831)

Subjects:

Comparison in baseline variables between efficacy group and non-efficacy group. by Naruyoshi Gyoutoku (22537831)

Subjects:

Comparison of ALT (A), AST (B), and Fib-4 index (C) before and after imeglimin treatment in ALT ≥ 25 IU/L and ALT < 25IU/L groups. by Naruyoshi Gyoutoku (22537831)

Subjects:

Clinical characteristics at baseline and at the end of the study. by Naruyoshi Gyoutoku (22537831)

Subjects:

Clinical characteristics of the study population. by Hun Gi Lee (21526538)

“…The total number of patients who met with P-TAs was 26,842, with a 43.1% reduction from 17,105–9,737. A decrease was observed across all age groups; however, the rate was lower in the geriatric and severely injured groups. …”

Mean offspring production of the aphid population treated with different fungal isolates at a concentration of 3.2×10⁶. by Aime Cheoh Enoh (20141758)

Graph of the risk of bias for the included randomized controlled trials (A); Summary of the risk of bias for the included randomized controlled trials (B). by Zhuoyang Xia (21354186)

Graphs of surface roughness values of test specimens after testing with varying concentrations across different particle size groups (a) Ra, Rq (b) Rz (c) Sa, Sq (d) Sz, Sv. by Yang Li (7082)

Quantification of bacterial adhesion revealed a significant decrease in the adhesion of <i>S. aureus</i>, <i>S. epidermidis</i>, and <i>P. aeruginosa</i> on blotted corneas of mice treated with 0.5% bupivacaine (BUP) combined with topical (TOP) application, following subconjunctival injection (SCI) of CGRP, 24 hours before the final BUP treatment (day 14) and again one hour prior to the final bupivacaine injection on day 15. by Ananya Datta (19932144)